Added therapeutic benefit of a new treatment compared with standard care
The Added Therapeutic Benefit (ASMR) is an evaluation issued by the HAS to measure the clinical improvement of a new drug compared with existing treatments.
ASMR is ranked from I to V, reflecting the level of innovation provided. This rating directly impacts price negotiations and reimbursement decisions.
A high ASMR (added therapeutic value) leads to stronger market positioning and favourable pricing, while a low ASMR may reduce economic impact even if the drug obtains marketing authorisation.
